Franklin King

Franklin King, a director at the Massachusetts General Hospital Center for the Neuroscience of Psychedelics and a Harvard Medical School faculty member, dives deep into the impact of psychedelics on the brain. He discusses how substances like psilocybin disrupt the default mode network, fostering neuroplasticity and leading to therapeutic breakthroughs. The conversation also touches on the correlation between mystical experiences and treatment outcomes, as well as the significance of the claustrum and 5-HT2A receptors in these processes.